November 19, 2010 - 8:55 AM EST
Nov. 19, 2010 (Marketwire) --
NEW YORK, NY -- (Marketwire) -- 11/19/10 -- Michelex Corporation (PINKSHEETS: MLXO) ("Michelex") announced that its wholly owned subsidiary, Pristine Pharma Corporation ("Pristine") participated in the Private Label Manufacturer's Association Trade Show in Chicago from November 14th to 16th 2010, held at the Rosemont Convention Center in Chicago. With its tremendously successful presentation at the trade show, Pristine showcased its offerings to buyers -- drugstores, supermarkets, mass merchandisers, convenience stores, discounters, exporters, and importers from over 35 countries. Pristine has reconnected with existing customers and acquainted with several new prospects, opening up opportunities for potentially exporting its OTC pharmaceutical products to Canadian and other international markets. Our strategically located manufacturing plant serves these markets very effectively.
In preparation for production, all of the manufacturing equipment for Pristine has arrived at the new 32,000 sq. ft. location in upstate New York. One competitive bid from among three contractors was selected for initial construction and shareholders will be pleased to learn that the construction work commenced last week. Bids are currently being secured for internal set up and installation of equipment and we expect to award the contract to a competitive bidder within a week. We are focused and committed to readying the plant for Pristine, to be self sufficient in producing our own Numed brand label products by January 2011.
Michelex Corporation, founded in 1999, is currently comprised of subsidiaries with a diversified portfolio of businesses in the areas of financial services and pharmaceutical drug manufacturing and distribution.
Pristine Pharma sells Over The Counter pharmaceutical products in store brand, private label and in its own control label, 'NUMED.'
This release may contain forward-looking statements within the meaning of the Private Securities Litigation reform Act of 1995. These statements and the matters discussed in this news release are forward-looking statements that involve a number of important risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to, the acquired companies' extremely limited operating history, the performance of the acquired companies, as well as other economic, competitive and technological factors involving the acquired companies' operations, markets, services, products and prices, uncertainties related to the acquired companies' access to additional capital, the ability of the acquired companies to enter into contracts with new customers, and dependency on key management.
Albert Lacle, CEO, Michelex Corporation, 204 Haledon Ave, Prospect Park, NJ 07508
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1429752
Add to Digg Bookmark with del.icio.us Add to Newsvine
For further information please contact our IR at: